Highly resistant E. coli strain found in NYC hospital patients

Researchers identified a highly resistant strain of Escherichia coli in four patients at a hospital in New York City, according to a study published in Antimicrobial Agents and Chemotherapy.

The E. coli strain contains a gene called mcr-1, which renders the bacteria resistant to colistin — an antibiotic of last resort for many drug-resistant infections.

Researchers identified the bacteria while monitoring patients with weakened immune systems as part of a prospective surveillance study. Three of the patients harboring the antibiotic-resistant E. coli strain exhibited no symptoms of infection, which increases the risk of unknowingly spreading the bacteria to others.

"While mcr-1 has been described from other parts of the world, it has been very rare in the U.S.," lead author Anne-Catrin Uhlemann, MD, PhD, associate professor at Columbia University's Vagelos College of Physicians and Surgeons in New York City, said in a press release.

"The detection of this cluster demonstrates the potential for silent dissemination of mcr-1 in the U.S. hospital setting, through asymptomatic colonization," Dr. Uhlemann added. "Our findings represent the earliest known documented healthcare-associated cluster of mcr-1 in the United States and predates a recent report that occurred in 2017."

Copyright © 2025 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


You can unsubscribe from these communications at any time. For more information, please review our Privacy Policy
.
 

Articles We Think You'll Like